Resources

Filter by:

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Ragni MV, Rothenberger SD, Feldman R, Nance D, Leavitt AD, Malec L, Kulkarni R, Sidonio R Jr, Kraut E, Lasky J, Pruthi R, Angelini D, Philipp C, Hwang N, Wheeler AP, Seaman C, Machin N, Xavier F, Meyer M, Bellissimo D, Humphreys G, Smith KJ, Merricks EP, Nichols TC, Ivanco D, Vehec D, Koerbel G, Althouse AD.

Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis

A. H. James, B. A. Konkle, P. Kouides, M. V. Ragni, B. Thames, S. Gupta, S. Sood, S. K. Fletcher, C. S. Philipp